Qingdao Baheal Medical Inc
SZSE:301015
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Qingdao Baheal Medical Inc
Long-Term Debt
Qingdao Baheal Medical Inc
Long-Term Debt Peer Comparison
1099
601607
600998
000963
Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
Q
|
Qingdao Baheal Medical Inc
SZSE:301015
|
Long-Term Debt
¥808.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Long-Term Debt
¥18.5B
|
CAGR 3-Years
15%
|
CAGR 5-Years
30%
|
CAGR 10-Years
16%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Long-Term Debt
¥7.3B
|
CAGR 3-Years
31%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
50%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Long-Term Debt
¥2.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Long-Term Debt
¥205.1m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
49%
|
CAGR 10-Years
7%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Long-Term Debt
¥577.5m
|
CAGR 3-Years
18%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
17%
|
See Also
What is Qingdao Baheal Medical Inc's Long-Term Debt?
Long-Term Debt
808.4m
CNY
Based on the financial report for Dec 31, 2023, Qingdao Baheal Medical Inc's Long-Term Debt amounts to 808.4m CNY.
What is Qingdao Baheal Medical Inc's Long-Term Debt growth rate?
Long-Term Debt CAGR 1Y
456%
Over the last year, the Long-Term Debt growth was 456%.
You don't have any saved screeners yet
